Former President and Chief Financial Officer · TENAX THERAPEUTICS, INC. (TENX)

Michael Jebsen

A named executive officer of TENAX THERAPEUTICS in every fiscal year CompBrief holds from FY2017 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$980,375

Salary $321,401Stock awards $0

FY2020: $597,534

2nd of 5 named executive officers at Tenax Therapeutics by FY2021 total.

5 named officers on file for TENAX THERAPEUTICS, FY2021

Michael Jebsen’s pay file — $29

  • 5 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how TENAX THERAPEUTICS’s whole pay program stands against its peers

  • TENAX THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TENX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2022 (DEF 14A).

Free

Get Michael Jebsen’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Michael Jebsen compensation by year

TENAX THERAPEUTICS Summary Compensation Table · all 5 fiscal years held
In US dollars, as TENAX THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021
Salary$420,417$381,500$339,788$349,981$321,401
Bonus$0$175,000$0$0$0
Stock awards$0$175,000$0$0$0
Option awards$92,563$0$0$71,709$105,695
Non-equity incentive$82,875$124,313$59,753$175,844$149,858
Pension and deferred compensation$0$0$0$0$0
All other$0$0$0$0$403,421
Total$595,855$855,813$399,541$597,534$980,375

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TENAX THERAPEUTICS, INC. DEF 14A filed April 28, 2022, accession 0001654954-22-005509, and prior-year filings. Open the filing on EDGAR.

How this page was built: the TENAX THERAPEUTICS, INC. filed document, accession 0001654954-22-005509. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2022.

$596K
$856K
$400K
$598K
$980K
FY17
FY18
FY19
FY20
FY21
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option49,500—$1.18

Per the Outstanding Equity Awards at Fiscal Year-End table in TENAX THERAPEUTICS, INC.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

TENAX THERAPEUTICS’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Anthony DiTonnoFormer Chief Executive Officer$1,059,571
Michael Jebsen · this pageFormer President and Chief Financial Officer$980,375
Christopher GiordanoPresident and Chief Executive Officer$860,913
Stuart RichChief Medical Officer$818,315
Eliot LurierInterim Chief Financial Officer$25,900

The full TENAX THERAPEUTICS compensation record

free company brief

This page is one person within TENAX THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are TENAX THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Jebsen's compensation dossier · One-time report. No refunds.